Literature DB >> 8548761

Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.

D Zagzag1, D R Friedlander, J Dosik, S Chikramane, W Chan, M A Greco, J C Allen, K Dorovini-Zis, M Grumet.   

Abstract

The expression of the extracellular matrix glycoprotein tenascin-C (TN) is enhanced in human astrocytomas and correlates with angiogenesis. To determine whether vascular cells are able to synthesize TN, we investigated the expression of TN protein and mRNA in nine astrocytomas. Immunogold electron microscopy in two glioblastomas multiforme detected the presence of TN in an extracellular perivascular location and to a lesser extent among tumor cells, confirming light microscopy immunohistochemical findings. In situ hybridization of astrocytomas using a digoxigenin-labeled antisense riboprobe detected strong staining for TN mRNA in vascular cells, especially in hyperplastic vessels, including those at the invasive edge of the tumors but not in vessels of normal brains. We observed weaker staining in tumor cells indicating a higher level of TN mRNA in vascular than in tumor cells. No staining was detected with the sense probe. Moreover, we investigated the ability of human brain microvessel endothelial cells (HBMECs) in primary culture to synthesize TN in vitro. Western blot analysis of the culture supernatants from HBMECs detected large amounts of TN. Immunogold silver staining demonstrated the presence of TN on the surface of HBMECs and in the subendothelial matrix. The distribution of TN mRNA in vascular cells of astrocytomas and the ability of HBMECs to synthesize TN in vitro demonstrate that vascular cells, including endothelial cells, are a major source of TN associated with angiogenesis. Furthermore, our results suggest that TN expression may be associated with endothelial cell activation and may play an important role in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8548761

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.

Authors:  H Bouterfa; A R Darlapp; E Klein; T Pietsch; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study.

Authors:  H Uematsu; M Maeda; N Sadato; T Matsuda; Y Ishimori; Y Koshimoto; H Kimura; H Yamada; Y Kawamura; Y Yonekura; H Itoh
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

3.  Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.

Authors:  Lai Wang; Wei Wang; Prediman K Shah; Lei Song; Mingjie Yang; Behrooz G Sharifi
Journal:  Cardiovasc Pathol       Date:  2012-02-01       Impact factor: 2.185

4.  Tenascin-C expression in normal, inflamed, and scarred human corneas.

Authors:  H Maseruka; R E Bonshek; A B Tullo
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 5.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 6.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

7.  Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas.

Authors:  M Principi; M Italiani; A Guiducci; I Aprile; M Muti; G Giulianelli; P Ottaviano
Journal:  Neuroradiology       Date:  2003-03-05       Impact factor: 2.804

Review 8.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

Review 9.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Passive immunotherapeutic strategies for the treatment of malignant gliomas.

Authors:  Daniel T Nagasawa; Christina Fong; Andrew Yew; Marko Spasic; Heather M Garcia; Carol A Kruse; Isaac Yang
Journal:  Neurosurg Clin N Am       Date:  2012-07       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.